Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biomaterials Access Assurance Act

This article was originally published in The Gray Sheet

Executive Summary

House Commerce Committee unanimously recommends HR 872 be sent to the House floor without amendment during a June 24 mark up. The House Telecommunications, Trade and Consumer Protection Subcommittee had approved the bill June 17 ("The Gray Sheet" June 22, p. 9). HR 872 has been incorporated into a broader senate product liability bill, recently negotiated by Sens. Slade Gorton (R-Wash.), John Rockefeller (D-W.Va) and the White House ("The Gray Sheet" June 15, In Brief). The Senate bill is scheduled for a cloture vote July 7...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT010247

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel